Sonoma Pharmaceuticals Inc. (SNOA)
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2026 Financial Results
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2026 Financial Results
Dover Announces Second Quarter 2026 Earnings Release Date, Conference Call and Webcast
Granite Point Mortgage Trust Inc. Announces Second Quarter 2026 Common and Preferred Stock Dividends and Business Update
Dynex Capital Appoints Douglas Neal to Its Board of Directors
PennyMac Mortgage Investment Trust Announces Scott Sauer Joined Its Board of Trustees
Starwood Property Trust Announces $0.48 Per Share Dividend for Second Quarter 2026
Global Ship Lease Announces Affirmed Credit Ratings and Upgraded Outlook
Lumentum Chair of the Board, Penny Herscher, and CEO, Michael Hurlston to Participate in Rome Conference on AI, Ethics and Governance
Greystone Housing Impact Investors LP Announces Regular Quarterly Cash Distribution
Cronos Announces Extension of Share Repurchase Program to the Toronto Stock Exchange